Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab-Reference-Cited by-同舟云学术

Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab

Published:2007-06-19 Issue:12 Volume:146 Page:829
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Sandborn William J.¹,Rutgeerts Paul¹,Enns Robert¹,Hanauer Stephen B.¹,Colombel Jean-Frédéric¹,Panaccione Remo¹,D'Haens Geert¹,Li Ju¹,Rosenfeld Marie R.¹,Kent Jeffrey D.¹,Pollack Paul F.¹

Affiliation:

1. From the Mayo Clinic, Rochester, Minnesota; Universitaire Ziekenhuizen Leuven and Gasthuisberg, Leuven, Belgium; University of British Columbia, Vancouver, British Columbia, Canada; University of Chicago, Chicago, Illinois; Hôpital Claude Huriez and Centre Hospitalier et Universitaire de Lille, Lille, France; University of Calgary, Calgary, Alberta, Canada; Imelda General Hospital, Bonheiden, Belgium; and Abbott Laboratories, Parsippany, New Jersey, and Abbott Park, Illinois.

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 855 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti-Tumor Necrosis Factors;The Korean Journal of Gastroenterology;2024-08-25

2. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08

3. Upadacitinib Reduces Crohn’s Disease Symptoms Within the First Week of Induction Therapy;Clinical Gastroenterology and Hepatology;2024-08

4. Efficacy and safety of risankizumab by baseline corticosteroid use and achievement of corticosteroid‐free clinical and endoscopic outcomes in patients with moderately to severely active Crohn's disease;Alimentary Pharmacology & Therapeutics;2024-07-25

5. The potential for medical therapies to address fistulizing Crohn’s disease: a state-of-the-art review;Expert Opinion on Biological Therapy;2024-07-24